BGMS insider sold 13,111 shares at $1.828; now holds 251,509

Bio Green Med Solution (BGMS) insider activity: Yap Kim Choy, a director and 10% owner, reported a sale of 13,111 shares of common stock on 10/28/2025 at $1.828 per share (transaction code S).

Accepted by SEC EDGAR 10/30/2025 - 06:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Bio Green Med Solution (BGMS) insider activity: Yap Kim Choy, a director and 10% owner, reported a sale of 13,111 shares of common stock on 10/28/2025 at $1.828 per share (transaction code S). Following the transaction, he beneficially owned 251,509 shares, held directly. This update was disclosed on Form 4.

Insider Trade Summary

Net Seller: 13,111 shares

Net Sell 1 txn

Insider Yap Kim Choy

Role 10% Owner

Sold 13,111 shs ($24K)

Type	Security	Shares	Price	Value
Sale	Common Stock	13,111	$1.828	$24K

Holdings After Transaction: Common Stock — 251,509 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did BGMS disclose on Form 4?

A sale of 13,111 shares of common stock on 10/28/2025 at $1.828 per share (code S).

Who is the reporting person in BGMS's Form 4?

Yap Kim Choy, identified as a director and 10% owner.

How many BGMS shares were beneficially owned after the transaction?

251,509 shares beneficially owned following the reported sale.

What was the ownership form after the transaction?

Ownership is reported as Direct (D).

What was the transaction code used?

Transaction code S, indicating an open market or private sale of non-derivative securities.

What security was involved in the transaction?

Common Stock of Bio Green Med Solution, Inc. (BGMS).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yap Kim Choy

(Last) (First) (Middle)

18-25-3A THE WHARF RESIDENCE

TAMAN PUCHONG PRIMA

(Street)

PUCHONG N8 47200

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bio Green Med Solution, Inc. [ BGMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/28/2025		S		13,111	D	$1.828	251,509	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Yap Kim Choy	10/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.